Compile Data Set for Download or QSAR

Found 272 hits Enz. Inhib. hit(s) with all data for entry = 694   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287714 (US10085984, Example 92 | US11040034, Ex. No. 92) Show SMILES FCc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C15H11F3N4/c16-6-9-3-8(7-19-21-9)15-20-13-4-11(17)12(18)5-14(13)22(15)10-1-2-10/h3-5,7,10H,1-2,6H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287715 (US10085984, Example 93 | US11040034, Ex. No. 93) Show SMILES Cc1nncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1C Show InChI InChI=1S/C16H14F2N4/c1-8-9(2)21-19-7-11(8)16-20-14-5-12(17)13(18)6-15(14)22(16)10-3-4-10/h5-7,10H,3-4H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287717 (US10085984, Example 95 | US11040034, Ex. No. 95) Show SMILES FC(F)(F)c1cc(cnn1)-c1nc2ccc(Cl)nc2n1C1CC1 Show InChI InChI=1S/C14H9ClF3N5/c15-11-4-3-9-13(21-11)23(8-1-2-8)12(20-9)7-5-10(14(16,17)18)22-19-6-7/h3-6,8H,1-2H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287719 (US10085984, Example 97 | US11040034, Ex. No. 97) Show SMILES CCCCc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C18H18F2N4/c1-2-3-4-12-7-11(10-21-23-12)18-22-16-8-14(19)15(20)9-17(16)24(18)13-5-6-13/h7-10,13H,2-6H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial (Homo sapiens (Human))	BDBM287719 (US10085984, Example 97 | US11040034, Ex. No. 97) Show SMILES CCCCc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C18H18F2N4/c1-2-3-4-12-7-11(10-21-23-12)18-22-16-8-14(19)15(20)9-17(16)24(18)13-5-6-13/h7-10,13H,2-6H2,1H3	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287723 (US10085984, Example 101 | US11040034, Ex. No. 101) Show SMILES FC(F)c1cc(cnn1)-c1nc2ccc(F)c(F)c2n1C1CC1 Show InChI InChI=1S/C15H10F4N4/c16-9-3-4-10-13(12(9)17)23(8-1-2-8)15(21-10)7-5-11(14(18)19)22-20-6-7/h3-6,8,14H,1-2H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287724 (US10085984, Example 102 | US11040034, Ex. No. 102) Show SMILES Fc1cc2nc(-c3cnnc(S)c3)n(C3CC3)c2cc1F Show InChI InChI=1S/C14H10F2N4S/c15-9-4-11-12(5-10(9)16)20(8-1-2-8)14(18-11)7-3-13(21)19-17-6-7/h3-6,8H,1-2H2,(H,19,21)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287726 (US10085984, Example 104 | US11040034, Ex. No. 104) Show SMILES Cn1c(nc2cc(F)c(F)cc12)-c1cnnc(c1)C(F)F Show InChI InChI=1S/C13H8F4N4/c1-21-11-4-8(15)7(14)3-9(11)19-13(21)6-2-10(12(16)17)20-18-5-6/h2-5,12H,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287728 (US10085984, Example 106 | US11040034, Ex. No. 106) Show SMILES Fc1cc2nc(-c3cnnc4CCCCc34)n(C3CC3)c2cc1F Show InChI InChI=1S/C18H16F2N4/c19-13-7-16-17(8-14(13)20)24(10-5-6-10)18(22-16)12-9-21-23-15-4-2-1-3-11(12)15/h7-10H,1-6H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287736 (US10085984, Example 114 | US11040034, Ex. No. 114) Show SMILES COCc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C16H14F2N4O/c1-23-8-10-4-9(7-19-21-10)16-20-14-5-12(17)13(18)6-15(14)22(16)11-2-3-11/h4-7,11H,2-3,8H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287739 (US10085984, Example 117 | US11040034, Ex. No. 117) Show SMILES Fc1cc2nc(-c3cnnc(OCC4CC4)c3)n(C3CC3)c2cc1F Show InChI InChI=1S/C18H16F2N4O/c19-13-6-15-16(7-14(13)20)24(12-3-4-12)18(22-15)11-5-17(23-21-8-11)25-9-10-1-2-10/h5-8,10,12H,1-4,9H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial (Homo sapiens (Human))	BDBM287739 (US10085984, Example 117 | US11040034, Ex. No. 117) Show SMILES Fc1cc2nc(-c3cnnc(OCC4CC4)c3)n(C3CC3)c2cc1F Show InChI InChI=1S/C18H16F2N4O/c19-13-6-15-16(7-14(13)20)24(12-3-4-12)18(22-15)11-5-17(23-21-8-11)25-9-10-1-2-10/h5-8,10,12H,1-4,9H2	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287740 (US10085984, Example 118 | US11040034, Ex. No. 118) Show SMILES FC(F)(F)COc1cc(cnn1)-c1nc2ccc(cc2n1C1CC1)C#N Show InChI InChI=1S/C17H12F3N5O/c18-17(19,20)9-26-15-6-11(8-22-24-15)16-23-13-4-1-10(7-21)5-14(13)25(16)12-2-3-12/h1,4-6,8,12H,2-3,9H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287741 (US10085984, Example 119 | US11040034, Ex. No. 119) Show SMILES FC(F)c1cc(cnn1)-c1nc2cc(F)c(Cl)cc2n1C1CC1 Show InChI InChI=1S/C15H10ClF3N4/c16-9-4-13-11(5-10(9)17)21-15(23(13)8-1-2-8)7-3-12(14(18)19)22-20-6-7/h3-6,8,14H,1-2H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287742 (US10085984, Example 120 | US11040034, Ex. No. 120) Show SMILES FC(F)c1cc(cnn1)-c1nc2cc(F)c(cc2n1C1CC1)C#N Show InChI InChI=1S/C16H10F3N5/c17-11-5-12-14(4-8(11)6-20)24(10-1-2-10)16(22-12)9-3-13(15(18)19)23-21-7-9/h3-5,7,10,15H,1-2H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287743 (US10085984, Example 121 | US11040034, Ex. No. 121) Show SMILES Fc1cc2nc(-c3cnnc4CCCc34)n(C3CC3)c2cc1F Show InChI InChI=1S/C17H14F2N4/c18-12-6-15-16(7-13(12)19)23(9-4-5-9)17(21-15)11-8-20-22-14-3-1-2-10(11)14/h6-9H,1-5H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287744 (US10085984, Example 122 | US11040034, Ex. No. 122) Show SMILES FC(F)c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C15H11F3N4/c16-9-1-4-11-13(6-9)22(10-2-3-10)15(20-11)8-5-12(14(17)18)21-19-7-8/h1,4-7,10,14H,2-3H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287745 (US10085984, Example 123 | US11040034, Ex. No. 123) Show SMILES CSc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C15H12F2N4S/c1-22-14-4-8(7-18-20-14)15-19-12-5-10(16)11(17)6-13(12)21(15)9-2-3-9/h4-7,9H,2-3H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287746 (US10085984, Example 124 | US11040034, Ex. No. 124) Show SMILES CC(C)Sc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C17H16F2N4S/c1-9(2)24-16-5-10(8-20-22-16)17-21-14-6-12(18)13(19)7-15(14)23(17)11-3-4-11/h5-9,11H,3-4H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287747 (US10085984, Example 125 | US11040034, Ex. No. 125) Show SMILES FC(F)Sc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C15H10F4N4S/c16-9-4-11-12(5-10(9)17)23(8-1-2-8)14(21-11)7-3-13(22-20-6-7)24-15(18)19/h3-6,8,15H,1-2H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287749 (US10085984, Example 127 | US11040034, Ex. No. 127) Show SMILES FC(F)Oc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C15H10F4N4O/c16-9-4-11-12(5-10(9)17)23(8-1-2-8)14(21-11)7-3-13(22-20-6-7)24-15(18)19/h3-6,8,15H,1-2H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287751 (US10085984, Example 129 | US11040034, Ex. No. 129) Show SMILES CC(F)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C16H13F3N4/c1-8(17)13-4-9(7-20-22-13)16-21-14-5-11(18)12(19)6-15(14)23(16)10-2-3-10/h4-8,10H,2-3H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287758 (US10085984, Example 136 | US11040034, Ex. No. 136) Show SMILES CC(F)c1cc(cnn1)-c1nc2ccc(cc2n1C1CC1)C#N Show InChI InChI=1S/C17H14FN5/c1-10(18)15-7-12(9-20-22-15)17-21-14-5-2-11(8-19)6-16(14)23(17)13-3-4-13/h2,5-7,9-10,13H,3-4H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287653 (US10085984, Example 31 | US11040034, Ex. No. 31) Show SMILES CCS(=O)(=O)NCc1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C17H18FN5O2S/c1-2-26(24,25)20-10-13-7-11(9-19-22-13)17-21-15-6-3-12(18)8-16(15)23(17)14-4-5-14/h3,6-9,14,20H,2,4-5,10H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287662 (US10085984, Example 40 | US11040034, Ex. No. 40) Show SMILES CCn1c(nc2ccc(cc12)C#N)-c1cnnc(OC)c1 Show InChI InChI=1S/C15H13N5O/c1-3-20-13-6-10(8-16)4-5-12(13)18-15(20)11-7-14(21-2)19-17-9-11/h4-7,9H,3H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287628 (US10085984, Example 6 | US11040034, Ex. No. 6) Show SMILES CCc1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C16H15FN4/c1-2-12-7-10(9-18-20-12)16-19-14-6-3-11(17)8-15(14)21(16)13-4-5-13/h3,6-9,13H,2,4-5H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287637 (US10085984, Example 15 | US11040034, Ex. No. 15) Show SMILES Cc1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C15H13FN4/c1-9-6-10(8-17-19-9)15-18-13-5-2-11(16)7-14(13)20(15)12-3-4-12/h2,5-8,12H,3-4H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287626 (US10085984, Example 4 | US11040034, Ex. No. 4) Show SMILES Fc1ccc2nc(-c3cnnc(C=C)c3)n(C3CC3)c2c1 Show InChI InChI=1S/C16H13FN4/c1-2-12-7-10(9-18-20-12)16-19-14-6-3-11(17)8-15(14)21(16)13-4-5-13/h2-3,6-9,13H,1,4-5H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287629 (US10085984, Example 7 | US11040034, Ex. No. 7) Show SMILES OC(c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1)C(F)(F)F Show InChI InChI=1S/C16H12F4N4O/c17-9-1-4-11-13(6-9)24(10-2-3-10)15(22-11)8-5-12(23-21-7-8)14(25)16(18,19)20/h1,4-7,10,14,25H,2-3H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287632 (US10085984, Example 10 | US11040034, Ex. No. 10) Show SMILES Fc1ccc2nc(-c3cnnc(c3)N3CCOCC3)n(C3CC3)c2c1 Show InChI InChI=1S/C18H18FN5O/c19-13-1-4-15-16(10-13)24(14-2-3-14)18(21-15)12-9-17(22-20-11-12)23-5-7-25-8-6-23/h1,4,9-11,14H,2-3,5-8H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287633 (US10085984, Example 11 | US11040034, Ex. No. 11) Show SMILES Fc1ccc(cc1)N1CCN(CC1)c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C24H22F2N6/c25-17-1-4-19(5-2-17)30-9-11-31(12-10-30)23-13-16(15-27-29-23)24-28-21-8-3-18(26)14-22(21)32(24)20-6-7-20/h1-5,8,13-15,20H,6-7,9-12H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287634 (US10085984, Example 12 | US11040034, Ex. No. 12) Show SMILES CC(C)(O)c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C17H17FN4O/c1-17(2,23)15-7-10(9-19-21-15)16-20-13-6-3-11(18)8-14(13)22(16)12-4-5-12/h3,6-9,12,23H,4-5H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287636 (US10085984, Example 14 | US11040034, Ex. No. 14) Show SMILES Fc1ccc2nc(-c3cnnc4ccccc34)n(C3CC3)c2c1 Show InChI InChI=1S/C18H13FN4/c19-11-5-8-16-17(9-11)23(12-6-7-12)18(21-16)14-10-20-22-15-4-2-1-3-13(14)15/h1-5,8-10,12H,6-7H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287640 (US10085984, Example 18 | US11040034, Ex. No. 18) Show SMILES CC(C)NC(=O)CN1CCN(CC1)c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C23H28FN7O/c1-15(2)26-22(32)14-29-7-9-30(10-8-29)21-11-16(13-25-28-21)23-27-19-6-3-17(24)12-20(19)31(23)18-4-5-18/h3,6,11-13,15,18H,4-5,7-10,14H2,1-2H3,(H,26,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287641 (US10085984, Example 19 | US11040034, Ex. No. 19) Show SMILES Cc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C15H12F2N4/c1-8-4-9(7-18-20-8)15-19-13-5-11(16)12(17)6-14(13)21(15)10-2-3-10/h4-7,10H,2-3H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287643 (US10085984, Example 21 | US11040034, Ex. No. 21) Show SMILES CNc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C15H13F2N5/c1-18-14-4-8(7-19-21-14)15-20-12-5-10(16)11(17)6-13(12)22(15)9-2-3-9/h4-7,9H,2-3H2,1H3,(H,18,21)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287644 (US10085984, Example 22 | US11040034, Ex. No. 22) Show SMILES Fc1cc2nc(-c3cnnc(Cl)c3)n(C3CC3)c2cc1F Show InChI InChI=1S/C14H9ClF2N4/c15-13-3-7(6-18-20-13)14-19-11-4-9(16)10(17)5-12(11)21(14)8-1-2-8/h3-6,8H,1-2H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287645 (US10085984, Example 23 | US11040034, Ex. No. 23) Show SMILES COc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C15H12F2N4O/c1-22-14-4-8(7-18-20-14)15-19-12-5-10(16)11(17)6-13(12)21(15)9-2-3-9/h4-7,9H,2-3H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287646 (US10085984, Example 24 | US11040034, Ex. No. 24) Show SMILES CC(C)Oc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C17H16F2N4O/c1-9(2)24-16-5-10(8-20-22-16)17-21-14-6-12(18)13(19)7-15(14)23(17)11-3-4-11/h5-9,11H,3-4H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287647 (US10085984, Example 25 | US11040034, Ex. No. 25) Show SMILES CN(C)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C16H15F2N5/c1-22(2)15-5-9(8-19-21-15)16-20-13-6-11(17)12(18)7-14(13)23(16)10-3-4-10/h5-8,10H,3-4H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287648 (US10085984, Example 26 | US11040034, Ex. No. 26) Show SMILES CCn1c(nc2ccc(F)cc12)-c1cnnc(C)c1 Show InChI InChI=1S/C14H13FN4/c1-3-19-13-7-11(15)4-5-12(13)17-14(19)10-6-9(2)18-16-8-10/h4-8H,3H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287649 (US10085984, Example 27 | US11040034, Ex. No. 27) Show SMILES Fc1cc2nc(-c3cnnc(OCC(F)(F)F)c3)n(C3CC3)c2cc1F Show InChI InChI=1S/C16H11F5N4O/c17-10-4-12-13(5-11(10)18)25(9-1-2-9)15(23-12)8-3-14(24-22-6-8)26-7-16(19,20)21/h3-6,9H,1-2,7H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287650 (US10085984, Example 28 | US11040034, Ex. No. 28) Show SMILES COCCNc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C17H17F2N5O/c1-25-5-4-20-16-6-10(9-21-23-16)17-22-14-7-12(18)13(19)8-15(14)24(17)11-2-3-11/h6-9,11H,2-5H2,1H3,(H,20,23)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287651 (US10085984, Example 29 | US11040034, Ex. No. 29) Show SMILES COc1cc(cnn1)-c1nc2ccc(cc2n1C1CC1)C#N Show InChI InChI=1S/C16H13N5O/c1-22-15-7-11(9-18-20-15)16-19-13-5-2-10(8-17)6-14(13)21(16)12-3-4-12/h2,5-7,9,12H,3-4H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287652 (US10085984, Example 30 | US11040034, Ex. No. 30) Show SMILES Cc1cc(cnn1)-c1cc2ccc(F)cc2n1C1CC1 Show InChI InChI=1S/C16H14FN3/c1-10-6-12(9-18-19-10)15-7-11-2-3-13(17)8-16(11)20(15)14-4-5-14/h2-3,6-9,14H,4-5H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287654 (US10085984, Example 32 | US11040034, Ex. No. 32) Show SMILES Fc1cc2nc(-c3cnnc(NCC(F)(F)F)c3)n(C3CC3)c2cc1F Show InChI InChI=1S/C16H12F5N5/c17-10-4-12-13(5-11(10)18)26(9-1-2-9)15(24-12)8-3-14(25-23-6-8)22-7-16(19,20)21/h3-6,9H,1-2,7H2,(H,22,25)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287655 (US10085984, Example 33 | US11040034, Ex. No. 33) Show SMILES CCc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C16H14F2N4/c1-2-10-5-9(8-19-21-10)16-20-14-6-12(17)13(18)7-15(14)22(16)11-3-4-11/h5-8,11H,2-4H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287656 (US10085984, Example 34 | US11040034, Ex. No. 34) Show SMILES Clc1cc(cnn1)-c1nc2ccc(cc2n1C1CC1)C#N Show InChI InChI=1S/C15H10ClN5/c16-14-6-10(8-18-20-14)15-19-12-4-1-9(7-17)5-13(12)21(15)11-2-3-11/h1,4-6,8,11H,2-3H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287657 (US10085984, Example 35 | US11040034, Ex. No. 35) Show SMILES Cc1cc(cnn1)-c1nc2ccc(cc2n1C1CC1)C#N Show InChI InChI=1S/C16H13N5/c1-10-6-12(9-18-20-10)16-19-14-5-2-11(8-17)7-15(14)21(16)13-3-4-13/h2,5-7,9,13H,3-4H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B2, mitochondrial (Homo sapiens (Human))	BDBM287658 (US10085984, Example 36 | US11040034, Ex. No. 36) Show SMILES CN1CCN(CC1)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1 Show InChI InChI=1S/C19H20F2N6/c1-25-4-6-26(7-5-25)18-8-12(11-22-24-18)19-23-16-9-14(20)15(21)10-17(16)27(19)13-2-3-13/h8-11,13H,2-7H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 272 total )  |  Next  |  Last  >>

Jump to: